Español | Site Map

Amazon Malaria Initiative

Call for Nominations for Malaria Champions of the Americas 2015
June 25, 2015
Description: Wednesday, July 1, 2015 is the deadline to nominate organizations for the annual Malaria Champions of the Americas competition. AMI’s partner, the Pan American Health Organization (PAHO/WHO), joins with several other organizations each year to sponsor a competition that recognizes innovative efforts to fight malaria in Latin America and the Caribbean. Full details and nomination forms can be downloaded at:

World Malaria Day 2015
April 25, 2015
Description: The Amazon Malaria Initiative (AMI) recognizes the need for more research on malaria in pregnancy in Latin America and the Caribbean. The US Centers for Disease Control and Prevention (CDC) estimate that 4 in 100 pregnancies in the region are affected by malaria. The negative effects of malaria in pregnancy include prematurity, low birth weight, miscarriages, stillbirth, and congenital malaria in infants. In addition, malaria in pregnant women can result in anemia, an increased risk of severe malaria, and even death. As most of the region has a low incidence of malaria, intermittent preventive treatment in pregnancy (IPTp) is not recommended in Latin America and the Caribbean.

Detecting and treating malaria in pregnant women is important in order to defeat malaria in Latin America and the Caribbean. AMI partners such as the CDC recommend that pregnant women be screened for malaria at each antenatal care visit. Pregnant women who are diagnosed with malaria should receive differentiated treatment according to the treatment guidelines of each country. As with the general population, prompt and effective diagnosis is encouraged along with the use of insecticide-treated bed nets.

AMI has developed a set of region specific Strategic Orientation Documents with guidelines for malaria. The Strategic Orientation Documents cover the topics of drug resistance monitoring in low-incidence settings, vector control, pharmaceutical management, and medicine quality control. They can be found on the AMI Resources page and on the RAVREDA website at:

Malaria Partners’ Meeting and XIV AMI/RAVREDA Annual Evaluation Meeting
March 23-26, 2015
Location: Rio de Janeiro, Brazil
Description: The Pan American Health Organization, in coordination with the Ministry of Health of Brazil, will host the annual AMI/RAVREDA international partners’ meeting in Rio de Janeiro from March 24-26, 2015. The meeting’s purpose is to review progress, lessons learned, and the implementation of tools developed by AMI/RAVREDA partners. Malaria-endemic countries’ ministries of health that are on the frontlines of regional efforts against malaria will be present. Representatives of the United States Agency for International Development (USAID), US Centers for Disease Control and Prevention (CDC), US Pharmacopeial Convention (USP), the USAID-funded Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), and Links Media will attend on behalf of AMI/RAVREDA. Prior to the official opening, a Malaria Partners’ Meeting is also planned with other entities such as the Mexican Agency for International Development Cooperation (AMEXCID), the Clinton Health Access Initiative (CHAI), Global Fund to Fight AIDS, TB, and Malaria, the Haiti Malaria Elimination Consortium (HaMEC), IS Global, and Population Services International (PSI).

Haiti Malaria Elimination Consortium (HaMEC) Is Formed
February 26, 2015
Description: The Bill and Melinda Gates Foundation has awarded a $29.9 million grant to the US Centers for Disease Control and Prevention to lead the new Haiti Malaria Elimination Consortium (HaMEC). HaMEC’s objective will be to eliminate malaria from the island of Hispaniola by 2020. Eight other institutions make up the consortium. “We laud this expression of solidarity with efforts to eliminate malaria from the only two countries in the Caribbean [Haiti and the Dominican Republic] where transmission still exists...” said Dr. Keith Carter, Senior Advisor on Malaria and other Communicable Diseases with the Pan American Health Organization/World Health Organization, a consortium partner.

XIV National Malaria Research Meeting in Brazil
February 2015
Location: Sao Paulo, Brazil
Description: Brazil will host its XIV National Malaria Research Meeting from October 1-3, 2015. The theme of the meeting will be the scientific basis for eliminating malaria as a public health problem in Brazil. The meeting seeks to explore different aspects of human malaria and related experimental models, including new approaches and challenges to control, immunological and molecular determinants of pathogenesis, and new advancements in diagnosis and treatment, especially in the post-genome era. For more information, visit the meeting website.

Poster on Mobile and Migrant Populations in Thailand’s Cambodia and Myanmar Border Areas
November 2014
Description: This poster by the Malaria Consortium shows the results of a questionnaire survey conducted among migrants attending malaria clinics and border malaria posts in artemisinin resistance areas in September 2013. The survey was conducted to identify malaria knowledge, prevention behavior, and treatment-seeking behavior of migrants. This poster was presented at the 63rd annual American Society of Tropical Medicine and Hygiene on 3-6 November 2014 and at the Joint International Tropical Medicine Meeting on 2-4 December 2014.
To view the poster click here.

AMI/RAVREDA Guyana Shield Follow-Up Meeting
November 11-13, 2014
Location: Paramaribo, Suriname
Description: This meeting will be organized by the Pan American Health Organization (PAHO/WHO) with support from the Drug Resistance and Containment Unit of the WHO Global Malaria Programme (GMP).

The meeting's objectives are to:
  • discuss updates from the ongoing therapeutic efficacy trials in Guyana and Suriname and other activities proposed during previous meetings;
  • discuss ways to mitigate key challenges that contribute to the development of artemisinin resistance; and,
  • obtain country and stakeholder feedback on the “Plan for Artemisinin Resistance Containment and Elimination in South America” draft.

GMAP2 Country Consultation Took Place in Peru
October 2014
Location: Peru
Description: The Peruvian Ministry of Health (MINSA) hosted the country consultation on the Second Global Malaria Action Plan (GMAP2) for the years 2016-2025. The consultation meeting was organized together with the Roll Back Malaria Partnership, the Pan American Health Organization (PAHO/WHO) and NAMRU-6.

During the multi-sectoral meeting, discussions focused on challenges and opportunities for malaria control in a post-2015 era following the Millennium Development Goals. The results will be taken together with the results from a regional consultation meeting carried out last April to develop a Global Malaria Action Plan that also responds to the situation in countries of the Americas region. The final version of the GMAP2 will be presented in October 2015. Click here to read the country consultation report in Spanish.

WHO policy brief on malaria diagnostics in low-transmission settings
September 2014
Read more here.

Harvard University and Fiocruz Institute Sponsor a Malaria Research Course and Workshop from November 16-21, 2014
August 29, 2014
Location: Porto Velho, Brazil
Description: Harvard's Defeating Malaria initiative has teamed up with collaborators in Brazil to organize a course entitled "Malaria Control: From the Bench to the Field." The workshop will occur from November 16-18, and the course will take place from November 16-21 in Porto Velho, Brazil and environs. Graduate students and/or post-doctoral fellows from academic institutions in Brazil and Latin America can apply to participate here.

How Mosquitoes Find Hosts To Transmit Deadly Diseases
Medical News Today (October 3, 2011)
The carbon dioxide we exhale and the odors our skins emanate serve as crucial cues to female mosquitoes on the hunt for human hosts to bite and spread diseases such as malaria, dengue and yellow fever. Read more.

Plan to Reduce Malaria and Prevent its Reintroduction
Scoop (October 1, 2011)
Health officials from countries throughout the Americas have pledged new efforts to reduce the burden of malaria and to protect progress already made against the disease through a strategy and plan of action approved during the 51st Directing Council meeting of the Pan American Health Organization (PAHO). Read more.

Enzymes Possible Targets for New Anti-Malaria Drugs
Science Daily (September 28, 2011)
Researchers at the Perelman School of Medicine at the University of Pennsylvania, Monash University, and Virginia Tech have used a set of novel inhibitors to analyze how the malaria parasite, Plasmodium falciparum, uses enzymes to chew up human hemoglobin from host red blood cells as a food source. They have validated that two of these parasite enzymes called peptidases are potential anti-malarial drug targets. Read more.

Malaria deaths could vanish in ten years, claims report
SciDev.Net (September 26, 2011)
Global malaria deaths could be reduced to near-zero, and cases of infection cut by 75 per cent, within the next decade, a report claims. Read more.

Malaria vaccine trial raises hope
BBC (September 23, 2011)
Researchers are to expand a clinical trial of a new malaria vaccine after promising results in a preliminary study in Burkina Faso. Read more.

Malaria vaccine test results out this year
IPP Media (September 21, 2011)
The Ifakara Health Institute (IHI), in collaboration with the National Institute for Medical Research (NIMR), plans to announce test results of a research on malaria vaccination after its completion before the end of this year. Read more.

Drop In Malaria Incidence, Despite Climate Change
Medical News Today (September 19, 2011)
According to scientific journal PLoS ONE, new research discovered that incidents of malaria cases in the East African highlands have dropped dramatically. 10 years ago, the region experienced a surge in malaria incidents, which researchers associated with climate change. Read more.

En 10 años, Ecuador bajó el número de enfermos de malaria en un 99%
Expreso (September 15, 2011)
Al recordarse los primeros diez años de creación de la Iniciativa Amazónica contra la Malaria (AMI) la curva de incidencia de la enfermedad en el país ha disminuido en un 99%. Read more.

América Latina redujo la malaria a la mitad en 10 años pero tiene que seguir alerta
EFE (September 15, 2011)
Latinoamérica logró reducir la malaria en más de un 50 por ciento en los diez años que lleva funcionando la iniciativa para la erradicación de la malaria (AMI) que se celebran hoy pero los expertos advierten que no hay que bajar la guardia.
"Hemos ganado una batalla pero como siempre lo más difícil después de la guerra es mantener la paz", dijo la directora de la Organización Panamericana de la Salud (OPS), Mirta Roses, durante un evento para conmemorar estos diez años de lucha contra la malaria centrada en los países de la cuenca amazónica. Read more.

AMI+RAVREDA: Successful Global Health Milestone for Malaria
Research! America (September 15, 2011)
Today, at the Pan American Health Organization in Washington, D.C. the global health and international development communities joined together to celebrate ten successful years of collaboration between the USAID Amazon Malaria Initiative and PAHO's Amazon Network for the Surveillance of Antimalarial Drug Resistance (AMI + RAVREDA). A panel of distinguished speakers and a keynote address both reflected on the elements of success essential to this collaboration. Read more.

AMI+RAVREDA celebrate Decade of Success
Links Media (September 12, 2011)
USAID's Amazon Malaria Initiative (AMI) and the Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA) of the Pan American Health Organization (PAHO) will commemorate 10 years of advances in the regional fight against malaria and will call for a sustainable roadmap to control the disease in Latin America and the Caribbean Region. The event, titled "Celebrating 10 Years of Collaboration, Looking into the Future Together," will take place on September 15, 2011, at the Pan American Health Organization (PAHO) headquarters in Washington. D.C. Read more.

New Malaria Vaccine Passes Safety Test
VOA (September 10, 2011)
The fight against malaria may have taken a promising step forward with the latest tests of a new kind of vaccine, which aims to keep people healthy and prevent the infection from spreading. Read more.

Warming Guyana coast risks malaria resurgence
Alert Net (September 7, 2011)
Guyana is battling to prevent the spread of malaria as climate change brings higher temperatures and more rainfall, threatening to push the disease back into densely populated coastal regions. Read more.

Malaria decreases by 60 percent in Acre State, Brazil
USAID Brazil (September 6, 2011)
Mosquito nets provided to the population with the support of USAID plays a major role in the fall of malaria cases. Read more.

Microwave radiation to be tested to treat malaria
SciDev.Net (September 5, 2011)
Panamanian researchers have been granted US$1 million from the Gates Foundation to try microwave radiation on mice infected with malaria. Read more.

Malaria discovery gives hope for new drugs & vaccines
Health University of California (September 1, 2011)
An investigation into the mysterious inner workings of the malaria parasite has revealed that it survives and proliferates in the human bloodstream thanks in part to a single, crucial chemical that the parasite produces internally. Read more.

Research findings on malaria confusing
Daily Nation (August 29, 2011)
In a span of about two weeks, a similar number of reports on malaria, one of the most important diseases in the region, have been published with divergent but serious implications on the way forward. Read more.

Research findings on malaria confusing
Daily Nation (August 29, 2011)
In a span of about two weeks, a similar number of reports on malaria, one of the most important diseases in the region, have been published with divergent but serious implications on the way forward. Read more.

The malaria mosquito is disappearing - but it is not just good news
Lab Spaces (August 26, 2011)
The incidence of malaria in many African countries south of the Sahara is falling rapidly. A Danish-Tanzanian research group has discovered that the mosquito carrying the malaria parasite has practically disappeared from villages without organized mosquito control, and the researchers do not know why. Read more.

Insecticide resistance linked to malaria resurgence
SciDev.Net (August 24, 2011)
Scientists have linked growing insecticide resistance with a resurgence of malaria in Senegal. Researchers working in the village of Dielmo warned that new approaches may be needed to fight the malaria scourge on the continent. Read more.

Malaria: Researchers raise qualms over bednet programme
The Independent (August 22, 2011)
Insecticide-treated bednets, whose use is being widely promoted in Africa to combat malaria, may paradoxically be linked to local resurgence of the disease, according to concerns raised by a study. Read more.

Mosquitoes 'developing resistance to bed nets'
BBC (August 17, 2011)
In recent years the nets have become a leading method of preventing malaria, especially in Africa. In the Lancet Infectious Diseases, the researchers also suggest the nets reduced the immunity of older children and adults to malaria infection. Read more.

Malaria killing more birds than it did 20 years ago
Yahoo News (August 15, 2011)
Malaria is killing off a growing number of British birds including sparrows, chaffinches, owls and nightingales, experts say. Read more.

The importance of considering community-level effects when selecting insecticidal malaria vector control products
Parasites and vectors (August 13, 2011)
Insecticide treatment of nets, curtains or walls and ceilings of houses represent the primary means for malaria prevention worldwide. Direct personal protection of individuals and households arises from deterrent and insecticidal activities which divert or kill mosquitoes before they can feed. Read more.

Malaria Watch TV: Interview USAID Administrator Rajiv Shah
Malaria Policy Center (August 11, 2011)
USAID Administrator, Dr. Rajiv Shah, sits down with the Malaria Policy Center to discuss foreign assistance and malaria issues. Read more.

Malaria Watch TV: Interview Rear Admiral Tim Ziemer, U.S. Global Malaria Coordinator
Malaria Policy Center (August 11, 2011)
Rear Admiral Tim Ziemer, U.S. Global Malaria Coordinator, took a moment to speak with the Malaria Policy Center about the status of the malaria fight and how the U.S. is leading the way against this preventable and treatable disease. Read more.

Attacking Malaria with Spermless Mosquitoes
Discovery News (August 10, 2011)
In the fight against malaria, researchers have devised a way to create spermless male mosquitoes able to convince females to reproduce with them, according to a study in the Proceedings of the National Academy of Sciences. Read more.

Guyana: 90 percent of malaria cases from Regions One, Seven, Eight
Kaiteur News (August 8, 2011)
In Guyana, 90 percent of the 11,828 persons tested positive for malaria for the first half of 2011 are from Regions One, Seven and Eight, says Minister of Health, Dr. Leslie Ramsammy. Malaria is a mosquito-borne disease caused by a parasite called Plasmodium. Read more.

Microwaves Join Fight Against Malaria
Medical News Today (August 6, 2011)
With the support of a Phase II grant from the Bill and Melinda Gates Foundation, Penn State materials scientists and medical researchers are working to develop a process to destroy malaria parasites in the blood using low-power microwaves. Read more.

Targeting Innate Immunity in Malaria: Novel DNA Sensing Pathway Linked to Increased Susceptibility to Malaria
Science Daily (August 5, 2011)
Scientists at the University of Massachusetts Medical School have uncovered a novel DNA-sensing pathway important to the triggering of an innate immune response for malaria. Read more.

Event: 'Does a pregnancy malaria vaccine have a place in the anti-malaria campaign and in global health improvement?'
Malaria LSHTM (August 2, 2011)
A pregnancy malaria (PM) vaccine could prevent many of the maternal  deaths associated with placental malaria infection and a large proportion of the >200,000 annual infant deaths in Africa attributable to low birth weight. Event on Tuesday 9th August 2011. Read more.

Event: The Science Behind Malaria Control and Eradication
Medical News Today (August 1, 2011)
The 2011 Malaria Conference in Tuscany, Italy, will bring together leading scientists from diverse disciplines to focus on "The Science behind Malaria Control and Eradication" on July 31 - August 5, 2011. Read more.

Neglected Tropical Disease Control Can Help In The Fight Against HIV/AIDS
Medical News Today (July 28, 2011)
There is a growing body of evidence revealing the connection between neglected tropical diseases (NTDs) and HIV/AIDS, prompting experts to call for greater integration of national NTD treatment programs with HIV/AIDS initiatives. Read more.

'Dirty sock smell' lures mosquitoes to a sticky end
CNN (July 27, 2011)
Researchers in Tanzania have chemically reproduced the stench of smelly feet in an innovative new approach to combat the spread of malaria in the country. Read more.

A New Target To Inhibit Malaria And Toxoplasmosis Infection
Medical News Today (July 26, 2011)
Researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques (Laboratory of Dynamics of Membrane Interactions in Normal and Pathological Cells - CNRS/ Montpellier Universities 1 and 2), have characterised a protein complex that allows the agents that cause malaria and toxoplasmosis to infect host cells. Read more.

Anti-Malaria Drug Chloroquine Finding May Lead to Treatments for Arthritis, Cancer and Other Diseases
Science Daily (July 22, 2011)
In a study published recently in the journal Science Signaling, Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers. Read more.

Making Blood-Sucking Deadly For Mosquitoes
Medical News Today (July 19, 2011)
Inhibiting a molecular process cells use to direct proteins to their proper destinations causes more than 90 percent of affected mosquitoes to die within 48 hours of blood feeding, a team of biochemists at the University of Arizona found. Read more.

Head lice drug may stem spread of malaria
The Angeles Times (July 16, 2011)
U.S. researchers in Senegal have found that ivermectin helps kill off disease-carrying mosquitoes that feed from people with the drug in their system. Read more.

Malaria parasite uses antibody camouflage to hide
ABC News (July 13, 2011)
Scientists from Rigshospitalet - Copenhagen University Hospital - and the University of Copenhagen have discovered malaria parasites use a type of antibody camouflage to hide from the immune system in the placentas of pregnant women, according to research published in the Proceedings of the National Academy of Sciences. Read more.

Simple measures 'could improve malaria diagnostic kits'
SciDev.Net (July 11, 2011)
Rapid diagnostic tests (RDTs) for malaria could be greatly improved by a few simple measures, say researchers. Read more.

Malaria vaccine researchers make breakthrough
ABC News (July 5, 2011)
Professor Michael Good from Griffith University says the work has shown that a small number of malaria parasites "hide" in white blood cells and escape treatments targeting red cells and the liver. Read more.

Malaria funding rise fills drug pipeline – report
Reuters (June 28, 2011)
Annual funding for research and development (R&D) in the fight against malaria has quadrupled over 16 years, generating the strongest pipeline of potential treatments in history, according to a report. Read more.

USP will present the Medicines Quality Database (MQDB) in a free webcast
USP (June 22, 2011)
The information contained in the MQDB is the result of collaborative studies performed with local stakeholders from countries in Africa, South America and Southeast Asia. This free and public resource will serve as an important tool for regulators, manufacturers, pharmacists, public health officials, national control laboratory representatives and patients. Read more.

New Weapon Found in War on Mosquitoes
NTD TV (June 21, 2011)
In a climate-controlled vault deep in the bowels of Vanderbilt University Center for Molecular Neuroscience, live thousands of Anopheles mosquitoes, also known as the malaria mosquito. Read more.

Complement Genomics involved with anti-malaria drugs
Nebusiness (June 17, 2011)
IT'S seen as a key component in many anti-malaria drugs, but the challenge of managing Artemisinin is more complicated than just sticking it on a list and picking it up from the shops. Read more.

Malaria Vaccination Strategy Provides Model for Superior Protection
Science Daily (June 15, 2011)
Malaria is a devastating disease caused by the Plasmodium parasite which is transmitted to humans by infected mosquitoes. Hundreds of millions of new cases of malaria are reported each year, and there are more than 750,000 malaria-related deaths annually. As a result, there is an urgent need for vaccines to combat infection. Read more.

New Evidence of Genetic 'Arms Race' Against Malaria
Science Daily (June 13, 2011)
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back. Read more.

Research Aims To Explore Untapped Opportunities To Combat Malaria Parasite In Liver
Medical News Today (June 10, 2011)
A scientist from The Scripps Research Institute has won a four-year, $1.9 million grant from the National Institutes of Health to better understand the parasite that causes malaria, laying the groundwork to develop better drugs to combat the widespread and deadly disease. Read more.

Scientists Launch Vaccine Research Foundation
PR Newswire (June 8, 2011)
Fourteen leading scientists and advocacy experts in vaccines and infectious diseases have announced the formation of a new international Foundation to advance and accelerate vaccine research and development against infectious diseases. The Foundation for Vaccine Research will be headquartered in Washington, DC. Read more.

GSK, J&J to trial next-generation malaria vaccine
Reuters (June 7, 2011)
Even as the world's first malaria vaccine gets closer to the market, two leading drug firms have joined forces to test a next-generation shot against the mosquito-borne disease that kills 800,000 people a year. Read more.

'Malaria in pregnancy' film inaugurated
IPP Media (June 6, 2011)
An educative film- 'malaria in pregnancy' was inaugurated in Dar es Salaam yesterday by the Ministry of Health and Social Welfare in Tanzania. Read more.

H.P. Tests Mobile Technology in Fight Against Malaria
New York Times (June 6, 2011)
For years Hewlett-Packard has been equated with computers and printers. The company is looking to be a player in a new era of mobile health monitoring. Read more.

Mosquitoes are suckered in new malaria research
The Independent (June 5, 2011)
In the biggest lab breakthrough against malaria in years, scientists on Wednesday said they had identified odour molecules that baffle blood-thirsty mosquitoes. Read more.

Examples from malaria control in refugee camps
Blog AAA (June 3, 2011)
Approximately half of the world's population is at risk of malaria, particularly those living in lower-income countries, according to the World Health Organization (WHO). The WHO calculates that every 30 seconds a child dies of malaria. Read more.

AMI-RAVREDA Workshop: Malaria prevention and control among populations under special circumstances
June 1, 2011
Representatives from Bolivia, Brasil, Colombia, Ecuador, Perú, USAID and PAHO participated in the meeting. Among the important messages related to this workshop are:
During the past decade, the number of malaria cases reported in the Americas dropped more than 50%. Today, malaria transmission has stopped in many areas in our countries (though we cannot talk about its elimination yet), but continues in others, affecting in particular populations living in what we may call special circumstances (such as temporary migrants working in the collection of Brazilian nuts or gold mining in the Amazon forest, Amazon native communities, and distant communities). In them, conventional strategies for malaria prevention and control do not work or cannot be implemented.
  In the region, only in very few occasions a systematic approach has been applied to malaria prevention and control in a population living under special circumstances, such as in the case of the experience with Brazilian nut collectors in Bolivia, and the miner population in Suriname. The workshop has made evident the need for a thorough approach to this subject, since it represents one of our main challenges for AMI for the coming years if we aim to decrease the risk of malaria re-emergence in the Americas. Read more.

Malaria protein overturns conventional wisdom of how cells move
Newstrack (May 31, 2011)
A new study has shown that the decades-long understanding of the relationship between protein structure and cell movement is flawed, by solving the structure of a protein that cuts power to the cell 'motor'. Read more.

Scientists find genetic basis for key parasite function in malaria
Physorg (May 26, 2011)
Investigators from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found the genes that malaria parasites use to create these feeding pores. Read more.

A 2020 vision for vaccines against HIV, tuberculosis and malaria
Nature (May 25, 2011)
Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five million deaths per year, but have nonetheless eluded conventional vaccine development; for this reason they represent one of the major global public health challenges as we enter the second decade of the twenty-first century. Read more.

Research Advances in Malaria, Spain, 2-3 June 2011
Johns Hopkins Malaria Research Institute (May 23, 2011)
The third annual Johns Hopkins Malaria Research Institute Research Advances in Malaria conference at the GSK Medicines Development Campus in Tres Cantos, Spain on Thursday 2 June and Friday 3 June 2011. The two-day international meeting will address critical issues in malaria drug development from pre-clinical to clinical studies. Read more.

Wolbachia Bacteria Reduce Parasite Levels And Kill The Mosquito That Spreads Malaria
Medical News Today (May 20, 2011)
Wolbachia are bacteria that infect many insects, including mosquitoes. However, Wolbachia do not naturally infect Anopheles mosquitoes, which are the type that spread malaria to humans. Researchers at the Johns Hopkins Bloomberg School of Public Health found that artificial infection with different Wolbachia strains can significantly reduce levels of the human malaria parasite, Plasmodium falciparum, in the mosquito, Anopheles gambiae. Read more.

Malaria Risk Reduced by Genetic Predisposition for Cell Suicide, Study Finds
Science Daily (May 19, 2011)
A human genetic variant associated with an almost 30 percent reduced risk of developing severe malaria has been identified. Scientists from the Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, and Kumasi University, Ghana, reveal that a variant at the FAS locus can prevent an excessive and potentially hazardous immune response in infected children. Read more.

Geographic profiling may help target malaria, AIDS and TB
Yahoo News (May 18, 2011)
A new study has shown that geographic profiling, a technique used in the hunt for serial killers, can also help combat infectious diseases such as malaria, HIV/AIDS and tuberculosis. Read more.

Malaria blocks 'super-infection'
BBC (May 15, 2011)
A team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host. Read more.

A Pre-Existing Malaria Infection Can Prevent A Second Infection
Medical News Today (May 15, 2011)
The malaria parasite can ensure it keeps a host body all to itself by preventing further malarial infections, according to international researchers. Read more.

Bacterium Found to Kill Malaria in Mosquitoes
ScienceDaily (May 13, 2011)
Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a bacterium in field-caught mosquitoes that, when present, stops the development of Plasmodium falciparum, the parasite that causes malaria in humans. According to the study, the Enterobacter bacterium is part of the naturally occurring microbial flora of the mosquito's gut and kills the parasite by producing reactive oxygen species (or free radical molecules). The study is published in the May 13 edition of Science. Read more.

WHO/PLoS Collection "Sin investigación no hay salud": A Call for Papers
WHO/PLoS Collection (May 9, 2011)
The World Health Report (WHR) for 2012 will be on the theme of "No Health without Research". This flagship report from WHO will, for the first time in its history, focus on research for better health. Read more.

First Low-Cost And Simple Technology Accurately Diagnoses Malaria In Field Settings Without Blood Collection
Medical News Today (May 6, 2011)
Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings. Read more.

HIV Drugs Can Also Target Tropical Parasites, Study Suggests
Science Daily (May 3, 2011)
Scientists have discovered that drugs used to treat HIV may also one day become lifesaving drugs targeted at parasitic diseases such as leishmaniasis and malaria. Read more.

New discovery opens up novel strategy for combating malaria
DNA India (May 1, 2011)
A group of researchers has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. Read more.

How Sickle Hemoglobin Protects Against Malaria
Science Daily (April 29, 2011)
The latest issue of the journal Cell carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. Read more.

Seattle BioMed study to identify biomarkers for malaria vaccine design
News Medical (April 28, 2011)
In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity. Read more.

Study Uncovers Genes That Aid Malarial Resistance
Check Orphan (April 27, 2011)
U.S. researchers have identified 11 genes that malaria parasites use to defend themselves against standard treatments, a finding that could prolong the life of current drugs or help find better ones. Read more.

"Malaria Champions of the Americas" Seeks Nominations of Integrated Approaches and Synergies in Efforts against Malaria
PAHO (April 26, 2011)
On the occasion of World Malaria Day, the Pan American Health Organization (PAHO), Pan American Health and Education Foundation (PAHEF), and the George Washington University Center for Global Health (CGH) today launched this year's search for the "2011 Malaria Champions of the Americas." Read more.

UN calls for intensified efforts to reach goal of no more deaths from malaria
UN (April 25, 2011)
The world must dramatically step up its existing efforts to conquer malaria if it is to reach the goal of near zero deaths from the disease – which, despite being preventable and curable, currently kills almost 800,000 people every year – by 2015, the United Nations warns today. Read more.

WHO calls for rational use of anti-malarial drugs
My Republica (April 25, 2011)
The World Health Organization (WHO) has called for rational use of anti-malarial drugs owing to the threat of the malaria parasites becoming resistant to the drugs. Read more.

Malaria: between hope and fear
RNW (April 25, 2011)
Malaria still kills thousands of people a day. That's distressing when you consider it's a disease that can not only be combated, but even eradicated Read more.

RBM Partnership marks a decade of progress on World Malaria Day 2011
RBM (April 22, 2011)
Commemorations of World Malaria Day taking place in donor and endemic countries this week highlight the considerable progress reached in the last decade, with key international figures urging an extraordinary intensification of efforts and clear plans for attaining the goal of near zero deaths by 2015. Read more.

Scientists manipulate mosquitoes in malaria fight
Reuters (April 21, 2011)
Scientists working on malaria have found a way of genetically manipulating large populations of mosquitoes that could eventually dramatically reduce the spread of the deadly disease. Read more.

World Malaria Day: When a Simple Initiative Conveys Great Results
PR Newswire (April 19, 2011)
April 25th marks the fourth annual celebration of World Malaria Day. Under this year's umbrella theme of Achieving Progress and Impact, the international community will again focus on the goal of achieving near zero malaria deaths by 2015, and how different stakeholders are contributing to reaching this target. Read more.

Global switch needed on severe malaria drug: MSF
Reuters (April 19, 2011)
Up to 200,000 deaths from severe malaria could be averted each year if malarial countries were to switch to a more expensive but more effective drug, the medical charity Medecins Sans Frontieres (MSF) said Tuesday. Read more.

Malaria or no malaria, prevention is decisive
IPP Media (April 18, 2011)
How so easy – but yet how so difficult! That, in a way, summarisies how Tanzania has found its war on malaria over the years. Read more.

Malaysian monkey malaria 'could spread in humans'
Scidev Net (April 15, 2011)
Monkeys in Malaysian forests are a reservoir for a rare form of malaria that could become a significant cause of disease in humans throughout South-East Asia, a study warns. Read more.

International Malaria Conference in Oslo
Norway Post (April 13, 2011)
The Oslo International Malaria Conference opened Tuesday. The focus of the two-day conference is the eradication of the dreaded disease. The Conference theme was "Getting to zero - Innovation through partnerships to end malaria deaths by 2015". Read more.

Fighting Malaria With African Plant Extracts
Science Daily (April 12, 2011)
Plants used in traditional African medicine may have an effect on the malaria parasite as well as the mosquitoes that spread the disease. A Norwegian pilot project is now indexing and testing these plants. Read more.

Letting There Be More Mosquitoes May Lead To Fewer Malaria Deaths, Say Researchers
Medical News Today (April 11, 2011)
It may seem counter-intuitive at first but letting mosquitoes grow up and breed may be part of the solution to tackling the devastating impact of malaria. Read more.

Increase in malaria deaths concern Dominican health authorities
Dominican Today (April 9, 2011)
After reporting six deaths due to malaria this year, Dominican health authorities launched an education campaign to fight the spread of the disease. Read more.

Students aim to combat malaria with smartphone software
Reuters (April 8, 2011)
A team of graduate students has created a new smartphone application they say will allow healthcare workers in remote locations to diagnose malaria cases on the spot. Read more.

Misuse of antibiotics undermining global fight against diseases like tuberculosis and malaria: WHO
Daily News (April 7, 2011)
The World Health Organization (WHO) said the misuse and irrational use of antibiotics has undermined the global fight against tuberculosis and malaria, warning of a possible return to the days before the drugs were developed. Read more.

High recombination rates and hotspots in a Plasmodium falciparum genetic cross
7th Space Interactive (April 4, 2011)
The human malaria parasite Plasmodium falciparum survives pressures from the host immune system and antimalarial drugs by modifying its genome. Genetic recombination and nucleotide substitution are the two major mechanisms that the parasite employs to generate genome diversity. Read more.

Tackle counterfeits to fight drug-resistant malaria
Scidev Net (April 1, 2011)
Malaria programmes promote artemisinin-based combination therapies (ACT) — powerful, life-saving medicines used to manage malaria — making them available in every country where the disease is endemic. Read more.

12 Million Euro Project To Develop New Tools For Malaria Control
Medical News Today (March 30, 2011)
LSTM has launched a collaborative project to develop and evaluate new tools to control the spread of malaria in Africa. Read more.

Study finds malaria as a serious problem for patients with landmine injuries
News Medical (March 25, 2011)
Malaria can complicate the course of disease in poor farmers with landmine injuries in underdeveloped countries, where both malaria and war injuries are frequent causes of illness and death. Read more.

X Annual Evaluation Meeting and the XIX Steering Committee Meeting for the Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance
March 22-25, 2011
Country and international partners and stakeholders participate in the X Annual Evaluation Meeting and the XIX Steering Committee Meeting for the Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance in Panama City, Panama, on March 21 to 25, 2011. The purpose of the joint meetings is to allow Amazon Malaria Initiative partners to exchange information about achievements and contributions, as well as lessons learned, made to malaria control efforts in the Latin American and Caribbean region, as a result of Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance. The materials and meeting presentations will be posted soon at Resources Section.

Specialists meet to discuss topics against malaria in the Americas
MINSA Panama (March 22, 2011)
The Americas countries, Geneva and international organizations met in Panama on Tuesday to celebrate the X Annual Evaluation Meeting and the XIX Steering Committee Meeting for the Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance. Read more.

Headway Is Being Made Fighting Communicable Diseases Globally, Research Suggests
Science Daily (March 14, 2011)
Those working for healthier humans around the globe are making headway in fighting communicable diseases such as AIDS, malaria and diarrheal illness, according to research from the Frederick S. Pardee Center for International Futures in the University of Denver's (DU) Josef Korbel School of International Studies. Read more.

Mosquitoes Have Different Evolutionary Strategies To Avoid Malaria
Medical News Today (March 9, 2011)
A team of researchers based at Cornell University and Institut Pasteur in Paris, show in a paper publishing today in the open access journal PLoS Biology, that both modes of evolution occur in critical anti-malaria genes of the vector mosquito Anopheles gambiae. Read more.

Malaria's Weakest Link: Class of Chemotherapy Drugs Also Kills the Parasite That Causes Malaria
Science Daily (March 8, 2011)
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Santé et de la Recherche Médicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease. Read more.

The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East
Parasites & Vectors (March 5, 2011)
This is the second in a series of three articles documenting the geographical distribution of 41 dominant vector species (DVS) of human malaria. The first paper addressed the DVS of the Americas and the third will consider those of the Asian Pacific Region. Read more.

The dominant Anopheles vectors of human malaria in the Americas
Parasites & Vectors (March 5, 2011)
An increasing knowledge of the global risk of malaria shows that the nations of the Americas have the lowest levels of Plasmodium falciparum and P. vivax endemicity worldwide, sustained, in part, by substantive integrated vector control. Read more.

Engineered fungus to be a potent tool against malaria
Sify News (February 28, 2011)
Scientists have genetically engineered a fungus to be a potent, specific and eco-friendly tool against malaria. Read more.

A Possible Safe New Way to Kill Mosquitoes That Spread Malaria
Voice of America (February 25, 2011)
Israeli researchers say they have developed a substance that attracts and kills mosquitoes infected with the malaria parasite. However, the sweet smelling substance is said to be harmless to people and animals. Read more.

Vaccine-delivering nanoparticles may help fight HIV, malaria
Sify News (February 23, 2011)
Engineers at MIT have come up with a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria. Read more.

Floating Spores Kill Malaria Mosquito Larvae
Science Daily (February 21, 2011)
New research published in BioMed Central's open access journal Parasites and Vectors presents a method of dispersing pathogenic fungi as a means of preventing the spread of malaria. Read more.

Malaria vaccine delivered through mosquito bites
TG Daily (February 16, 2011)
A health charity supported by the Bill & Melinda Gates Foundation has found a new way to inoculate against malaria - using mosquito bites. Read more.

Published Research Proposes A System For Spreading Disease-Resisting Genes In Mosquito Populations
Medical News Today (February 13, 2011)
Scientists have modeled a system that may be used to control mosquitoes and the diseases they transmit, without the use of pesticides. In the proposed system, mosquitoes are engineered to carry two genes. Read more.

Pesticide-Free Method Takes a Bite out of Mosquito-Borne Disease
Science Daily (February 11, 2011)
Scientists have modeled a system that may be used to control mosquitoes and the diseases they transmit, without the use of pesticides. In the proposed system, mosquitoes are engineered to carry two genes. The first gene causes males to transmit a toxin to females through their semen. The second gene, when expressed in females, makes them immune to this toxin. Read more.

Profiling Malaria-Causing Parasites
Science Daily (February 9, 2011)
The majority of fatal cases of malaria are caused by infection with the parasite Plasmodium falciparum. Most at risk are young children and women who are pregnant. A team of researchers has now developed an approach to profile P. falciparum parasites in such a way that they are able to identify parasite genes associated with severe infection. Read more.

Bednets And Preventative Treatment Reduce Malaria Infection In Children
Medical News Today (February 8, 2011)
A large-scale trial by the Medical Research Council (UK) The Gambia has corroborated the findings of two other trials in Mali and Burkina Faso, carried out to improve the health of children affected by malaria, an infection responsible for one in five childhood deaths in Africa. Read more.

Mosquito subspecies presents challenge in fighting malaria
Los Angeles Times (February 5, 2011)
Efforts to wipe out the disease have focused on indoor mosquitoes, but a newly discovered type that's more susceptible to the parasite lives outdoors, where it's harder to battle. Read more.

Scientists Discover Aggressive Outdoor Malaria Mosquito
Voice of America (February 4, 2011)
Scientists are expressing concern that a newly-discovered type of mosquito could mean larger and less easily controlled populations of insects carrying the deadliest form of malaria. Read more.

Intermittent drug treatment can curb malaria: study
AFP (February 3, 2011)
The intermittent use of preventive antimalarial drugs can be beneficial in curbing the spread of the disease in children, according to the results of a study. Read more.

Malaria scientists set sights on global eradication
SciDev.Net (January 27, 2011)
A suite of new tools against malaria will be needed to fulfill the ambitious new goal of total eradications, according to a report by 250 scientists. Read more.

MalERA: A Research Agenda For Malaria Eradication
Medical News Today (January 26, 2011)
A collection of 12 reviews, comprising three reflective pieces and nine research and development agendas, is published as part of a sponsored Supplement on 25 January 2011 in PLoS Medicine. This Collection highlights the outcomes of a series of consultations among more than 250 experts that were undertaken by the Malaria Eradication Research Agenda (malERA) initiative. Read more.

Malaria parasites caught in act of invading cells
Sify News (January 20, 2011)
Scientists relying on new imaging technologies have for the first time caught malaria parasites in the act of invading red blood cells (RBCs). Read more.

New malaria vaccine promising
Swiss Info (January 15, 2011)
A new experimental vaccine has shown promising results in protecting 53 percent of the African children against malaria in the first 8 months after receiving the shot, a new study says. Read more.

A plan to control Artemisinin-resistant malaria
Examiner (January 14, 2011)
The use of Artemisinin combination therapy (ACT) and insecticide treated bed nets is given credit for saving over 700,000 lives in Africa from 2000 to 2010. Read more.

Drug-Resistant Malaria Parasite Spread Must Be Stopped
Medical News Today (January 13, 2011)
If drug-resistant malaria parasite spread and development is not halted, there is a serious risk of significantly undermining the efficacy of current treatments for the disease, researchers reveal in an article published by the World Health Organization (WHO) and the Roll Back Malaria (RBM) partnership. Read more.

WHO launches plan to protect malaria therapies
Swiss Info (January 13, 2011)
The initiative, announced in Geneva, follows reports in Southeast Asia of the first signs of resistance to artemisinin, the key component of malaria treatments for millions of patients, posing a serious threat to global control efforts. Read more.

Drug-resistant malaria could spread fast, expert warns
Reuters (January 13, 2011)
Drug-resistant malaria could spread from southeast Asia to Africa within months, putting millions of children's lives at risk, a leading expert warned. Read more.

WHO global plan to contain drug-resistant malaria
Reuters (January 12, 2011)
The World Health Organization launched a plan on Wednesday to stop a form of drug-resistant malaria from spreading from Southeast Asia to Africa, where millions of lives could be at risk. Read more.

Scientists seek weakness in malaria parasite's life cycle
News Scotsman (January 7, 2011)
A study by Edinburgh University scientists has found when the malaria parasite is at its most harmful and when it is at its most vulnerable. Read more.

Learning to outwit malaria
Bulletin World Health Organization (January 4, 2011)
Dr Robert D Newman tells the WHO Bulletin why malaria programmes don't make headlines, why rapid diagnostic tests are the hottest new technology and why eradication is the only acceptable end-goal in beating this ancient scourge. Read more.

Malaria-Infected Cells Stiffen, Block Blood Flow
Medical News Today (December 30, 2010)
Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world. Read more.

Immunity in Emerging Species of a Major Mosquito Carrier of Malaria
Science Daily (December 22, 2010)
In notable back-to-back papers appearing in the journal Science in October, teams of researchers provided evidence that Anopheles gambiae, which is one of the major mosquito carriers of the malaria parasite in Sub-Saharan Africa, is evolving into two separate species with different traits. Read more.

Malaria Report Shows Rapid Progress Towards International Targets
Medical News Today (December 16, 2010)
The World malaria report 2010 describes how the drive to provide access to antimalarial interventions to all those who need them, called for by the UN Secretary-General in 2008, is producing results. Read more.

WHO claims gains in global fight against malaria
Associated Press (December 15, 2010)
A massive malaria control program since 2008 has helped reduce infections across Africa and eradicate the disease in Morocco and Turkmenistan, but a slowdown in funding risks undoing those achievements, the World Health Organization said Tuesday. Read more.

Scratch codes aid malaria fight
BBC (December 15, 2010)
A pilot scheme in the two nations has begun putting unique scratch codes on more than 500,000 medicine bottles and packets of pills. When the code is texted to a free phone number, a return message will reveal that a drug is genuine. Read more.

The cost of a malaria-free world
Swiss Info (December 14, 2010)
Joe Cohen, a scientist tantalisingly close to delivering the world's first malaria vaccine, is on the stump. After 23 years of painstaking laboratory work and a programme of major trials in seven countries, the 67-year-old biologist says the clinical case for the vaccine is almost proved. Read more.

New Approach to Blocking Malaria Transmission Developed
Science Daily (December 5, 2010)
University of Illinois at Chicago researcher Dr. John Quigley will describe a promising new approach to blocking malaria transmission during the American Society of Hematology's annual meeting in Orlando, Fla. Read more.

Bolivia's Official Medicine Control Laboratory Attains World Health Organization Prequalification
Links Media (December 1, 2010)
Amazon Malaria Initiative (AMI) announced today that Bolivia's Official Medicine Control Laboratory, or Laboratorio de Control de Calidad de Medicamentos y Toxicologia (CONCAMYT), has achieved World Health Organization (WHO) prequalification to test priority medicines relevant to public health programs and ensure the medicines meet appropriate quality standards. Read more.

WHO Fears Growing Malaria Drug Resistance May Be Spreading
Voice of America (November 28, 2010)
World Health Organization officials say there are signs of growing drug resistance to mosquito-borne malaria, raising concern millions of people in Asia may be at risk. WHO officials say counterfeit drugs and poor storage are to blame. Read more.

WHO Calls On Malaria-Endemic Countries To Strengthen Monitoring Of Antimalarial Drug Efficacy
Medical News Today (November 22, 2010)
WHO is calling on countries to be increasingly vigilant in monitoring antimalarial drug efficacy in order to allow for early detection of artemisinin resistance. Read more.

DDT: Less Is More In Malaria Control
The University of Queensland (November 19, 2010)
A new malaria study by UQ scientists challenges World Health Organization guidelines for using DDT chemical spray to kill mosquitoes. Read more.

Malaria: Killer Bug
Business (November 15, 2010)
How many does malaria really kill? The figure varies, but one thing's certain: It's much more than what's recorded. A study by medical journal Lancet throws up shocking numbers for malaria mortality in India. At 205,000 deaths annually, this is more than 13 times the World Health Organization's estimate of 15,000 and over 100 (136 to be precise) times the Indian government's piddling figure of 1,500 malaria deaths. Read more.

Malaria Drug Artesunate Found More Effective Than Quinine At Preventing Severe P. Falciparum Malaria Deaths In Children, Study Says
Medical News Today (November 10, 2010)
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) and published in The Lancet. Read more.

Commemoration of Malaria Day in the Americas
Links Media (November 4, 2010)
The Amazon Malaria Initiative (AMI) has announced its participation in the commemoration of the 2010 Malaria Day in the Americas, which is annually observed on November 6, to further public awareness about this infectious disease in the region. Read more.

Researchers Use Math, Maps To Plot Malaria Elimination Plan
Medical News (November 1, 2010)
Two University of Florida researchers and their international colleagues have used mathematical models and maps to estimate the feasibility of eliminating malaria from countries that have the deadliest form of the disease. Read more.

Scientists make malaria discovery
BBC (October 12, 2010)
Scientists in Edinburgh have discovered a gene in the malaria parasite, which enables it to develop resistance to certain drugs. Resistance to the plant-based remedy, artemisinin, potentially creates problems in controlling malaria. Read more.

Gene study could hold key to more anti-malaria treatments
News Scotsman (October 11, 2010)
Scottish scientists have identified genes that make some malaria-carrying mosquitoes resistant to insecticide. Researchers have pinpointed a gene that enables the parasite that causes the infection to resist treatment with the plant-based remedy artemisinin. Read more.

Global Malaria Control Funding Has Gone Up Significantly Since 2007, But Funding Shortfall Remains, Study Says
Medical News Today (October 5, 2010)
Global malaria funding has gone up by 166 percent since 2007, but total funding is still 60 percent short of the $4.9 billion required for comprehensive malaria control this year, according to a study published in the journal Lancet. Malaria control financing has risen from $730 million in 2007 to $1.94 billion this year, according to the analysis. Read more.

Malaria Experts Focus On RTS,S As Malaria Vaccines For The World Conference Begins
Medical News Today (September 30, 2010)
Scientists and physicians from around the world gathered in Washington, D.C. on Tuesday for the start of the second Malaria Vaccines for the World Conference. Read more.

Malaria Vaccine Development Meeting Begins In Washington
Medical News Today (September 29, 2010)
Agence France-Presse reports on a malaria vaccine development meeting that kicks off Tuesday in Washington, D.C. Read more.

Genomic Study of Malaria Parasite in Peru Reveals Evidence of Antibiotic Resistance
Science Daily (September 28, 2010)
A team of scientists from The Scripps Research Institute, the Genomics Institute of the Novartis Research Foundation (GNF), and the U. S. Naval Research Detachment in Peru has completed a study that could improve the efficacy of diagnosis and treatment strategies for drug-resistant malaria. Read more.

Global Fund requests support to fight against AIDS, tuberculosis and malaria
Global Found  (September 27, 2010)
More than 500, 000 signatures are being sought by the end of this month to ensure that world leaders stick to their promise to provide care, treatment and support to millions that suffer from three illnesses. The Global Fund to fight AIDS, tuberculosis and malaria.Read more.

Malaria's Newest Pathway Into Human Cells Identified
Science Daily (September 25, 2010)
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute, provides a new vaccine target through which infection with the deadly disease could be prevented.Read more.

Malaria parasite may have come from gorillas
Los Angeles Times (September 22, 2010)
One of the nastiest of the parasites that cause malaria may have originated in gorillas, scientists say after analyzing thousands of samples of primate feces. The findings may clear chimpanzees of much of the blame.Read more.

Nano-treated bednets last five times longer
SciDev Net (September 18, 2010)
Insecticide-treated bednets that retain their lethal qualities for up to five years may be possible after Thai researchers found a way of "locking in" the chemical they contain using nanotechnology.Read more.

'Exciting' new odour sensors found in malaria mosquitoes
SciDev Net (September 17, 2010)
An array of new mosquito repellents and lures may be possible following the discovery by researchers of a new set of sensors that the principal species of malaria-carrying mosquito uses to sniff out its targets.Read more.

Report: Prevention Efforts Averted Almost 750,000 Child Malaria Deaths Over 10 Years
Medical News Today (September 17, 2010)
Malaria prevention efforts - such as the use of bed nets, indoor insecticide spraying and the use of drugs to prevent the disease - have prevented the deaths of almost 750,000 children in 34 African countries over the past 10 years, according to a report released on Reuters. Read more.

USAID Initiative Raises Awareness of Malaria Medicine Quality
Links Media (September 15, 2010)
Sub-standard and counterfeit medicines exacerbate the malaria burden in the Amazon Basin but United States Agency for International Development’s (USAID’s) Amazon Malaria Initiative (AMI) is taking effective steps to improve the situation. A new AMI fact sheet, issued today, describes how the program recorded significant progress in fighting this infectious disease that annually strikes nearly a half a million people in the region. Read more.

Promising Malaria Drug Candidate Emerges
National Health Institute (September 13, 2010)
A chemical that rids mice of malaria-causing parasites after a single oral dose may, with further development and testing, lead to a new malaria drug. Health officials have made significant progress in controlling malaria, but the disease still kills nearly 1 million people worldwide every year, mostly infants and young children in Sub-Saharan Africa. Read more.

Incentive For New Drug Treatments
Medical News Today (September 12, 2010)
Drug companies may be more willing to develop treatments for neglected diseases including malaria, tuberculosis and leishmanaiasis if the European Union would adopt a "priority review voucher" reward system. Read more.

Peru’s Official Medicine Quality Control Laboratory Attains World Health Organization Laboratory Prequalification, Achievement Will Support Efforts To Improve Patient Access To Quality-Assured Priority Medicines
Lima-Peru (September 7, 2010)
Peru’s National Center for Quality Control, or Centro Nacional de Control de Calidad (CNCC), announced today that it has achieved World Health Organization (WHO) laboratory prequalification to test priority medicines relevant to public health programs and ensure they meet appropriate quality standards. The Prequalification Programme, a United Nations initiative managed by WHO, aims to make quality priority medicines available for the benefit of those in need. Read more.

Production of sticky proteins may explain how malaria evades the immune system Humans
Nature (September 7, 2010)
Researchers have discovered a new strategy that the malaria parasite, Plasmodium Falciparum, uses to make sure it evades the human immune system and thrives inside the body. Read more.

Single-Dose Of Experimental Malaria Drug Clears Parasites In Mice, Represents Potential New Class Of Drugs To Treat Malaria In Humans
Medical News Today (September 6, 2010)
An experimental malaria drug was shown to effectively treat the disease in mice with only a single dose, according to a study published Thursday in the journal Science. Reuters reports (Kelland, 9/2). The new drug, known as NITD609, "represents an entirely new class of medicines to treat malaria ... Human trials could begin later this year," the Wall Street Journal writes (Naik, 9/3). Read more.

New Antimalarial Compound Shows Promise For Drug Resistant Malaria
Medlical News Today (September 3, 2010)
Scientists are developing a new antimalarial drug with a novel mechanism of action which shows promise for clearing a Plasmodium (malaria parasite) infection after a single dose, according to an article published in the journal Science. Scientists say the antimalarial candidate, called spiroindolone NITD609 has a novel compound and will most likely be the next generation for drug resistant malaria. Read more.

Virus May Act as 'Evolution-Proof' Biopesticide Against Malaria
Science Daily (August 21, 2010)
A naturally occurring virus in mosquitoes may serve as a "late-life-acting" insecticide by killing older adult mosquitoes that are responsible for the bulk of malaria transmission. The researchers from Johns Hopkins University and the Johns Hopkins Malaria Research Institute, Baltimore, Maryland, detail their findings in the August 2010 issue of the Journal of Virology. Read more.

Good Riddance to Mosquitoes: Four Ways to Beat the Malaria-Carrying Threat
Scientific American (August 19, 2010)
Mosquitoes that carry the Plasmodium parasite cause some 300 million cases of malaria every year, claiming one million lives. That's a lot of carnage generated by an insect smaller than a pinky fingernail—but if enterprising researchers have their way, their blood-thirsty assault won't continue much longer. There are some promising strategies for wiping out malaria-carrying mosquitoes. Read more.

AMI Meeting - Malaria Vector Control for Latin America
(August 17, 2010)
On behalf of the Amazon Malaria Initiative (AMI), U.S. Centers for Disease Control and Prevention (CDC) announced a Malaria Vector Control for Latin America Meeting to be held August 17-19, 2010 in Atlanta, USA. The meeting has the following objectives: (i) to develop a strategic orientation document for malaria vector control and surveillance for low to moderate transmission settings; (ii) to identified capacity building needs, and (iii) to established priorities on research. The speakers include AMI partners and representatives of CDC. Read more.

Elsevier Launches Malaria Nexus, Global Malaria Resource
PR Newswire (Aug. 11, 2010)
Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet(R), The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology. Read more.

German scientists discover 'needle-free' malaria vaccine
Deutsche Welle (Aug. 9, 2010)
By combining antibiotics and malaria-infected mosquitos, researchers find that mice are protected. Human clinical trials will be just around the corner. Deep in a lab, in carefully sealed incubators, mosquitos, which normally are malaria carriers, may this time actually be part of the solution. Read more.

Understanding the Malaria-Causing Parasite
U.S. News (Aug. 6, 2010)
In the early part of the 20th century, German-born biochemist Hans Krebs figured out one of the most universal ways living things use nutrients in order to produce energy, grow and reproduce. His discovery of the cycle, which was named for him, led to a Nobel Prize in 1953. Read more.

Metabolic Pathway Found in Malaria Parasites; Possible Drug Targets
Science Daily (Aug. 5, 2010)
A newly described metabolic pathway used by malaria-causing parasites may help them survive inside human blood cells. The finding, by researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, clarifies the picture of parasite metabolism and provides clues to potential weak points in the pathway that might be attacked with drugs. Read more.

Antibiotics could vaccinate against malaria, says study
SciDev.Net (August 5, 2010)
Malaria sufferers might be able to protect themselves against life-threatening bouts of the disease by taking a single course of antibiotics, research in mice has shown. Read more.

Experts roll out malaria map, urge mosquito study
Reuters (Aug. 4, 2010)
Nearly 3 billion people, or two-fifths of the world's population, were at risk of contracting malaria in 2009 and closer study of the mosquito's life cycle is needed to combat the disease, researchers said in two reports. Read more.

Adherence to Atovaquone-Proguanil Malaria Prophylaxis
Journal watch (Aug. 2, 2010)
Traveler-reported adherence was high; adverse effects were uncommon. Most cases of malaria in travelers are the result of not receiving an appropriate chemoprophylactic agent or not taking it as prescribed — i.e., before, during, and after travel. Just how common is nonadherence? Read more.

Amazon Malaria Initiative Workshop on Vector Control, Aug. 2-7 in Honduras
(Aug. 2, 2010)
On behalf of the Amazon Malaria Initiative (AMI), the Pan American Health Organization (PAHO) announced a medical entomology vector control workshop to be held August 2-7, 2010 in Tegucigalpa and Catamas, Honduras. The meeting will include theoretical and practical sessions on basic epidemiological concepts, insecticide-resistant mosquito surveillance and other topics. Read more.

New Methods, New Math Speed Detection of Drug-Resistant Malaria
ScienceDaily (Aug. 2, 2010)
Researchers at Case Western Reserve University developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drugs used against the disease. Read more.

AMI - Goals and Accomplishments
October 2001– May 2009

Links Media (August 2010)
The Amazon Malaria Initiative partners have published the Amazon Malaria Initiative: Goals and Accomplishments, a multiyear report which summarizes important information about this initiative from October 2001 to May 2009. This report explains AMI’s subregional approach which has promoted evidence-based decision-making in the Amazon Basin region and fosters multi-country collaboration. Additionally, it reports on the needs, activities, and major accomplishments within the AMI technical areas: antimalarial medicine resistance; diagnostic quality assurance and access to diagnosis; antimalarial medicine quality; antimalarial medicine access and use; vector control, insecticide resistance, and entomology; and communication and information dissemination. Read more.

Ecology: A world without mosquitoes
Nature (July 22, 2010)
Malaria infects some 247 million people worldwide each year, and kills nearly one million. Mosquitoes cause a huge further medical and financial burden by spreading yellow fever, dengue fever, Japanese encephalitis, Rift Valley fever, Chikungunya virus and West Nile virus. Read more.

Antibiotics Might Protect Against Malaria
VOA News (July 19, 2010)
People at high risk of contracting malaria might be protected by taking a combination of simple, inexpensive antibiotics. That is the finding of a new study by researchers who say the drugs rally the body's immune system against the mosquito-borne parasite. Read more.

Scientists Create 'Malaria-Proof' Mosquito
Medline Plus (July 16, 2010)
In what might someday be a major advance against one of the world's most devastating diseases, researchers say they've created a mosquito that is unable to infect humans with malaria. The University of Arizona team reported that their genetically altered mosquitoes are immune to the malaria-causing parasite, a single-cell organism called Plasmodium. Read more.

Drugs + Mosquitoes = Malaria Vaccine?
Medline Plus (July 14, 2010)
Scientists have been working for decades to develop a vaccine against malaria, but the Plasmodium parasite is a formidable foe. Now a team of scientists has come upon what could be a relatively simple alternative: Two antibiotics already in widespread use can act as a sort of malaria vaccine in mice. If the find holds up in humans, it could be an inexpensive and relatively safe tool to help control the disease, they say. Read more.

Testing of Natural Products and Synthetic Molecules Aiming at New Antimalarials
Current Drug Targets (July 13, 2010)
The search for new antimalarials, which in the past relied on animal models, is now usually performed with cultures of Plasmodium falciparum (PF) blood parasites by evaluation of parasite growth inhibition. Field isolates of PF human malaria parasite, parasite strains and clones, well characterized for their susceptibility to chloroquine and other standard antimalarials are available for the in vitro tests. Read more.

US expert sees widening resistance to malaria drug
AFP (July 12, 2010)
Resistance to new anti-malarial medication appears to be spreading beyond the western Cambodia area where it was first detected, according to a US health official. The World Health Organization (WHO) warned early last year that parasites resistant to the drug artemisinin had emerged along the border between Cambodia and Thailand. Read more.

In search of a real solution to the counterfeit problem
InPharm (July 12, 2010)
For a great deal of the last decade, warnings from the pharmaceutical industry about the growing threat of counterfeit medicines seemed to go unheeded in Europe. Increasing levels of seizures and detection of fake medicines gradually made politicians sit up and take notice, however, and by 2008 the European Commission was investigating how to introduce new laws and regulations. Read more.

Johns Hopkins Malaria Research Institute Named International Center of Excellence
JHMRI News (July 9, 2010)
The Johns Hopkins Malaria Research Institute (JHMRI) is one of 10 centers selected by the National Institute for Allergy and Infectious Diseases (NIAID) as an International Center of Excellence in Malaria Research (ICEMR). NIAID, part of the National Institutes of Health, established the network of centers to accelerate the control and elimination of malaria worldwide. Read more.

U.S. FDA panel explores boost for rare drugs
JHMRI News (July 8, 2010)
U.S. regulators are exploring how to make it easier and cheaper for drug companies to develop treatments for rare diseases -- an underserved slice of the market that typically offers slim profits. The U.S. Food and Drug Administration already offer companies grants and guaranties seven years of market exclusivity for drugs that treat rare diseases. Read more.

Antimalarial drugs: A treasure trove of potential antimalarials
Nature Reviews Drug Discovery (July 7, 2010)
The battle to control malaria infection has been hampered by many factors, including emerging drug resistance. Now, two papers published in Nature have opened up the door to a wealth of compounds that can be explored in the development of novel antimalarials, in particular against Plasmodium falciparum, the parasite species that causes the most deaths. Read more.

Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine
Malaria Journal (July 5, 2010)
It is argued that, the efficacy of anti-malarials could be prolonged through policy-mediated reductions in drug pressure, but gathering evidence of the relationship between policy, treatment practice, drug pressure and the evolution of resistance in the field is challenging. Read more.

NIAID Invention Gaining Acceptance in Malaria-Endemic Countries
Nihrecord (July 1, 2010)
The World Health Organization recently announced that it had approved 15 additional rapid diagnostic tests (RDTs) for malaria, bringing the total number that meet its performance criteria to 37. WHO called rapid tests a major breakthrough in malaria control, as they enable health workers to diagnose malaria accurately in people living in remote rural areas, where most malaria cases occur. Read more.

Antioxidants May Help Prevent Malaria Complicaton That Leads to Learning Impairment
ScienceDaily (June 25, 2010)
Using an experimental mouse model for malaria, an international group of scientists has discovered that adding antioxidant therapy to traditional antimalarial treatment may prevent long-lasting cognitive impairment in cerebral malaria. Their findings were published online June 24, 2010, in the journal PLoS Pathogens. Read more.

Peru’s Medicine Quality Control Lab Achieves Additional ISO/IEC Accreditation
Lima, Peru (June 23, 2010)
Peru’s National Center for Quality Control, or Centro Nacional de Control de Calidad (CNCC), announced that it has officially received additional ISO/IEC 17025:2005 accreditation to conduct seven more critical analytical tests from Assured Calibration and Laboratory Accreditation Select Services (ACLASS). Now Peru’s CNCC is certified by the internationally recognized accrediting body to handle 12 types of tests that cover nearly 90% of its laboratory workload. This accreditation assures the quality of antibiotics, antimalarials and other medications distributed in Peru. Read more. (In Spanish)   Press release

AMI - Goals and Accomplishments
October 2001– May 2009

Links Media (June 22, 2010)
The Amazon Malaria Initiative partners have published the Amazon Malaria Initiative: Goals and Accomplishments, a multiyear report which summarizes important information about this initiative from October 2001 to May 2009. This report explains AMI’s subregional approach which has promoted evidence-based decision-making in the Amazon Basin region and fosters multi-country collaboration. Additionally, it reports on the needs, activities, and major accomplishments within the AMI technical areas: antimalarial medicine resistance; diagnostic quality assurance and access to diagnosis; antimalarial medicine quality; antimalarial medicine access and use; vector control, insecticide resistance, and entomology; and communication and information dissemination. Read more.

Alternative Pathway to Malaria Infection Identified
ScienceDaily (June 21, 2010)
Discovery of a key red cell molecule used by the malaria parasite gives renewed hope for an effective vaccine in the future, according to an international team of researchers. Read more.

Cleared forests lead to rise in malaria in Brazil
Reuters (June 17, 2010)
Clearing forests in the Amazon helps mosquitoes thrive and can send malaria rates soaring. They found a 48 percent increase in malaria cases in one county in Brazil after 4.2 percent of its tree cover was cleared. Read more.

Amazon Malaria Initiative Partners Speak at Global Health Council Conference in Washington, D.C.
June 16 and 17
Two technical experts working with the Amazon Malaria Initiative (AMI) will speak about accomplishments in malaria control and prevention, and new approaches to improving pharmaceutical management in the region.

When: Wednesday, June 16, 2010 - 12:45 p.m.
What: Amazon Malaria Initiative: A strategic approach to assist in malaria control and prevention in the Amazon Basin.
Speaker: Dr. Pablo Aguilar, Links Media
Where: Speaker’s Corner (Aisle 700 of the Exhibit Hall) Omni Shoreham Hotel (Metro Red Line: Woodley Park) 1500 Calvert Street NW, Washington, DC 20008

When: Thursday, June 17, 2010 - 10:30 a.m.
What: Removing Roadblocks: Effective Approaches in Improving Pharmaceutical Management. Developing Supervision Systems for Antimalarial Supply in Latin America.
Speaker: Angélica Pérez, Management Sciences for Health
Where: Executive Room Omni Shoreham Hotel (Metro Red Line: Woodley Park) 1500 Calvert Street NW, Washington, DC 20008

Click here for more information about the Global Health Council Conference

Malaria epidemic hits southern Venezuela
Associated Press (June 4, 2010)
Malaria cases have doubled in Venezuela so far this year as health officials confront an epidemic in a vast southern region where wildcat gold miners are often infected in remote jungle camps. Health Ministry statistics published this week show there have been 21,601 malaria cases nationwide so far this year, up from 10,758 during the same period last year. Read more.

Cerebral Malaria: Scientists Advance Understanding of Deadly Form of Malaria in Children
ScienceDaily (June 1, 2010)
Scientists are making strides against cerebral malaria, a fatal form of malaria in children that can ravage the brain and is extremely difficult to treat. New research points to platelets -- known for their role in blood clotting -- as playing an important role in the disease, stimulating the immune system and turning on molecules that increase inflammation. The inflammation leads to the obstruction of blood vessels in the brain, causing brain damage similar to that seen with a stroke. Read more.

Spokespersons Training for AMI partners
Links Media conducted a Web-based videoconference "Elements for Communicating as a Spokesperson for AMI/RAVREDA" on May 27 for international and national AMI partners. The objectives of the videoconference were to increase knowledge of how to clearly and effectively communicate about AMI/RAVREDA; and to present tools to help prepare for communication activities related to AMI/RAVREDA.
The participants were educated about the difference between a communicator and spokesperson, developed reliable and pertinent messages related to specific AMI/RAVREDA technical areas, and increased their awareness about the AMI/RAVREDA materials and tools available for dissemination.
Please, click here to download the presentation.

Researchers Find Novel Anti-Malarial Drug Candidate In Multicenter Study
Medical News Today (May 27, 2010)
As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs. Read more.

Malaria Control to Overcome Disease’s Spread as Climate Warms
ScienceDaily (May 23, 2010)
Contrary to a widespread assumption, global warming is unlikely to expand the range of malaria because of malaria control, development and other factors that are at work to corral the disease. Read more.

New Species of Human Malaria Recognized
ScienceDaily (May 20, 2010)
Scientists investigating ovale malaria, a form of the disease thought to be caused by a single species of parasite, have confirmed that the parasite is actually two similar but distinct species which do not reproduce with each other, according to research published in The Journal of Infectious Diseases. Read more.

New Twist on Potential Malaria Drug Target Acts by Trapping Parasites in Cells
ScienceDaily (May 17, 2010)
Harvard School of Public Health (HSPH) researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites within infected blood cells, potentially containing the disease. Read more.

Rapid diagnosis test for malaria effective in Amazonia
SciDev.Net (May 16, 2010)
After comparing methods for diagnosing malaria, Brazilian scientists have suggested which is the most effective in urban and rural populations in the Amazon. (In Spanish) Read more.

How the Parasite Responsible for Severe Forms of Malaria Can Resist a Major Antimalarial Agent
ScienceDaily (May 5, 2010)
Researchers have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the first-line drugs used to treat this disease. Read more.

Mosquitoes inherit DEET resistance
Nature News (May 3, 2010)
The indifference of some mosquitoes to a common insect repellent is due to an easily inherited genetic trait that can be rapidly evolved by later generations, a new study suggests. Read more.


President Malaria Initiative Releases 6-Year Malaria Strategy
USAID (April 26, 2010)
The U.S. government Thursday released a six-year strategy to address malaria globally. The plan was issued through the President's Malaria Initiative (PMI) in conjunction with World Malaria Day, April 25, and is a "core component of President Obama's Global Health Initiative," according to a USAID press release. Read more.

April 25: World Malaria Day
April 25, 2010
April 25, 2010, marks the third annual World Malaria Day, a day set aside to call attention to malaria and to mobilize action to combat it.
Read more.

AMI partners analyzed alternative Malaria Treatment at Regional Meeting in Colombia
April 22, 2010
Management Sciences for Health, a partner of Amazon Malaria Initiative (AMI), announced that it convened a regional technical meeting to analyze current patterns of malaria treatment in Amazon region. The event took place in Cartagena, Colombia, April 13-15, 2010, on the eve of World Malaria Day and focused on alternatives to improving malaria treatment in AMI partner countries in the Amazon Basin.
"AMI’s multipronged, evidence-based approach assesses the effectiveness of current drugs, develops new treatment policies, improves drug quality and accessibility," said Dr. Jaime Chang, USAID. "AMI improves diagnostic accuracy, promotes integrated vector control, and devises social media tactics that serve to educate the people of the Amazon Basin regarding prevention measures and access to effective treatments." Read more.

Malaria in the Americas 2010: Innovative Solutions from the Ground
April 19, 2010
In commemoration of World Malaria Day 2010, The Pan American Health Organization, The Pan American Health and Education Foundation, The Global Health Network, and The Center for Global Health at The George Washington University cordially invite you to attend the Malaria in the Americas 2010: Innovative Solutions from the Ground.

The event will feature videos, presentations and discussions on malaria and its continuing challenge in the Americas, and the work of ‘Malaria Champions of the Americas.’

WHEN: Thursday, April 22, 2010
TIME: 12:00 p.m. to 1:00 p.m.
WHERE: Ross Hall, Room 101, 2300 I Street, NW, Washington, DC 20037
Read more.

World Malaria Day, April 25
April 7, 2010
Approximately half of the world's population is at risk of malaria, particularly those living in lower-income countries. It infects more than 500 million people per year and kills more than 1 million. Read more.

IX Annual Evaluation Meeting and the XVII Steering Committee Meeting for the Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance
Links Media participated in the IX Annual Evaluation Meeting and the XVII Steering Committee Meeting for the Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance in Santa Cruz, Bolivia, on March 2 to 5, 2010.

The purpose of the joint meetings was to allow Amazon Malaria Initiative partners to exchange information about contributions made to malaria control efforts in the Latin American and Caribbean region, as a result of Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance.

Seven Amazon Malaria Initiative partner countries (Bolivia, Brazil, Colombia, Ecuador, Peru, Suriname, and Guyana) and five guest countries (French Guyana, Guatemala, Honduras, Nicaragua, and Panama) participated in this meeting, each providing key information regarding lessons learned and best practices for malaria control.

International AMI partners in attendance included United States Agency for International Development, United States Centers for Disease Control and Prevention, Pan American Health Organization, Links Media, Management Sciences for Health, and United States Pharmacopeia, and representatives had the opportunity to share the details of ongoing collaborative activities in each Amazon Malaria Initiative country.

Guest speakers from the World Health Organization, the Oxford University Division of Tropical Medicine, and the Worldwide Antimalarial Resistance Network provided keynotes on specific malaria control interventions and innovations.

For more information, and access to meeting presentations, please visit Selected Presentations in Resources.

Global Fund seeks $20 bln for AIDS, malaria, TB
AFP (March 24, 2010)
The Global Fund for AIDS, malaria and tuberculosis treatment in poor countries called on rich states Wednesday to supply up to 20 billion dollars (15 billion euros) for 2011-2013. Read more.

United Nations Special Envoy for Malaria Announces the Social Media Envoy Group
Office of Special Envoy (March 15, 2010)
Today, United Nations Special Envoy for Malaria, Ray Chambers, announced the formation of a Social Media Envoy group chartered with inspiring and activating social media audiences throughout the year in support of malaria control. Read more.

Gates says malaria vaccine may be ready in three years
January 26, 2010
Source: BBC News Online
Just like smallpox, Mr. Gates believes the disease can be eradicated. As yet, there is no vaccine, but, Mr Gates says, a breakthrough is near. Read more.

New Drug Targets For Malaria Cure
January 12, 2010
Researchers are a step closer to developing new antimalarial drugs after discovering the normal function of a set of proteins related to the malaria parasite protein, which causes resistance to the front-line drug chloroquine. The findings also provide a novel tool for studying the malarial chloroquine-resistance factor... read more.

Climate change increasing malaria risk
December 31, 2009
UK-funded research shows climate change has caused a seven-fold increase in cases of malaria on the slopes of Mount Kenya. Rising temperatures on the slopes of Mount Kenya have put an extra 4 million people at risk of malaria, research funded by the UK government warned today. Climate change has raised average temperatures in the Central Highlands region of Kenya, allowing the disease to creep into higher altitude areas where the population has little or no immunity.The findings by a research team funded by the UK Department for International Development (DfID), showed that seven times more people are contracting the disease in outbreaks in the region than 10 years ago.The team from the Kenyan Medical Research Institute (Kemri) said that while similar outbreaks elsewhere have been attributed ... read more.

To a mosquito, matchmaking means 'singing' in perfect harmony
December 31, 2009
(Cell Press) Researchers have new insight into the sex lives of the much-maligned mosquitoes that are responsible for the vast majority of malaria deaths, according to a report published online on Dec. 31 in Current Biology, a Cell Press publication. In finding a partner of the right species type, male and female mosquitoes depend on their ability to "sing" in perfect harmony. Those tones are produced and varied based on the frequency of their wing beats in flight. (Source: EurekAlert! - Social and Behavioral Science)

2009 Malaria Champions of the Americas Awarded Today
November 6, 2009
Source: Pan American Health and Education Foundation The Pan American Health and Education Foundation (PAHEF) partnered with the Pan American Health Organization (PAHO) and The George Washington University for the third annual Malaria Day in the Americas to honor individuals and organizations fighting malaria within Latin America and the Caribbean. Read more.

Malaria Day in the Americas 2009
November 6, 2009
Source: Pan American Health and Education Foundation Approximately 57% of people living within the Americas are at risk of malaria infection. To draw attention to the issue, Malaria Day in the Americas will be observed for the third consecutive year on November 6, 2009. It will be the platform upon which countries of the Region can engage in a year-round aggressive campaign against the disease. Read more.

Malaria-Related News
More AMI Coverage:

AMI's Events Calendar

AMI calendar

DISCLAIMER:The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.

Contact Us | Privacy Statement| Join Our Email List

Last updated on: 6/30/2015